Skip to main content
. 2019 Jan 20;49(4):408–418. doi: 10.1111/apt.15113

Figure 5.

Figure 5

Clinical remission statusa at week 14 in patients with ulcerative colitis, stratified by estimated vedolizumab concentration quartiles from low (quartile 1) to high (quartile 4) at weeks 2, 4 and 6. P values were determined using the exact Cochran‐Armitage trend test. aClinical remission was defined as a partial Mayo Score of ≤2 points with no individual sub‐score >1 point. Patients were not case‐matched for this analysis